New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2014
10:18 EDTAET, HUM, UNH, UAM, WCG, CI, HNT, WLPCMS says Medicare Advantage reimbursement to rise in 2015
The Centers for Medicare & Medicaid Services announced Medicare Advantage and prescription drug rates for 2015. The agency estimated that its payments for Medicare Advantage beneficiaries would rise slightly, versus its previous estimate that such payments would fall. A Medicare Advantage Plan is a type of health plan offered by a private company that contracts with Medicare to provide subscribers with Part A and Part B benefits. WHAT'S NEW: CMS reimbursements for Medicare Advantage beneficiaries will rise 0.4%, CMS estimated, compared to a February proposal that contemplated a 1.9% cut. ANALYST REACTION: In a note to investors earlier today, FBR Capital analyst Steven Halper wrote that the final Medicare Advantage rates are a positive for health insurers with significant exposure to such plans. Companies in this category include Aetna (AET), Humana (HUM), and UnitedHealth (UNH), said Halper. He kept Outperform ratings on Aetna and United Health and a Market Perform rating on Humana. Another research firm, Leerink, said it views the "biggest positive" from the final rates that the CMS announced last night as the delay in the proposal to eliminate in home Health Risk Assessments to support reimbursement for high risk seniors. Leerink thinks the final rates are favorable for MA plans and estimates the positive impact in order: Humana, Universal American (UAM), WellCare (WCG), UnitedHealth, Cigna (CI), Aetna, Health Net (HNT) and WellPoint (WLP). PRICE ACTION: In early trading, Aetna rose fractionally to $72.70, UnitedHealth lost 0.6% to $80.59, Humana sank 1.8% to $109.95, and Universal American added 2c to $7.16.
News For AET;HUM;UNH;UAM;WCG;CI;HNT;WLP From The Last 14 Days
Check below for free stories on AET;HUM;UNH;UAM;WCG;CI;HNT;WLP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 2, 2014
08:34 EDTHUMHumana to reaffirm FY14 EPS view $7.25-$7.75, consensus $7.73
Members of Humana Inc.’s senior management team are scheduled to meet with investors at various times between September 3 and the end of the month. During such meetings, Humana’s management expects to reaffirm its guidance of $7.25-$7.75 in diluted EPS for the year ending December 31, 2014. This EPS guidance is consistent with that issued in Humana’s current report on Form 8-K filed with the U.S. SEC on July 30 and subsequently reiterated in investor presentations posted to the Investor Relations section of its web site.
August 31, 2014
14:00 EDTCIFBR Capital to hold a conference
Healthcare Conference to be held in Boston on September 3.
August 26, 2014
08:30 EDTHNTHealth Net Federal Services receives URAC disease management reaccreditation
Subscribe for More Information
August 24, 2014
21:53 EDTUNHNational Association of Chain Drug Stores to hold an expo
2014 NACDS Total Store Expo to be held in Boston on August 23-25.
August 21, 2014
16:09 EDTCICigna expects to reaffirm FY14 income guidance of $1.94B-$2.0B
Subscribe for More Information
August 20, 2014
08:31 EDTHNTCognizant deal with Health Net has encouraging read through, says Cowen
Cowen noted Cognizant (CTSH) shareholders were concerned over its deal with Health Net (HNT) but noted management feels the deal is a true partnership. The firm feels management's positive comments are encouraging and address the execution and profitability concerns of shareholders. Shares of Cognizant are Outperform rated with a $50 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use